We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Rocket Pharmaceuticals Inc
19 own
10 watching
Current Price
$10.71
$-0.37
(-3.34%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,577.42M
52-Week High
31.47000
52-Week Low
10.070000
Average Volume
1.43M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,577.42M52-Week High31.4700052-Week Low10.070000Average Volume1.43MDividend Yield--P/E Ratio--What does the Rocket Pharmaceuticals Inc do?
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company. The Company is advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Its lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia, a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia. It also has two clinical stages and one pre-clinical stage in vivo adeno-associated virus (AAV) programs, including programs for Danon disease, Plakophilin-2 Arrhythmogenic Cardiomyopathy and BAG3 Dilated Cardiomyopathy.
Read More
How much money does Rocket Pharmaceuticals Inc make?
News & Events about Rocket Pharmaceuticals Inc.
Zolmax
1 year ago
StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT Get Rating) to a sell rating in a report issued on Wednesday. Several other equities research analysts have also recently commented on RCKT. William Blair reaffirmed an outperform rating on shares of Rocket Pharmaceuticals in a ...
Benzinga
1 year ago
Rocket Pharma (NASDAQ: RCKT) CEO Gaurav Shah is on a mission to "change the narrative" when it comes to rare diseases.
read more...
Zolmax
1 year ago
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT Get Rating) has earned a consensus rating of Moderate Buy from the fourteen analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and twelve have issued a buy recommendation on the ...
Ticker Report
2years ago
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT Get Rating) have received a consensus rating of Moderate Buy from the thirteen brokerages that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation ...
Business Wire
2years ago
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces updates from the Company's end-of-Phase 1 meeting with the U.S. Food and...
Frequently Asked Questions
Frequently Asked Questions
What is Rocket Pharmaceuticals Inc share price today?
Can Indians buy Rocket Pharmaceuticals Inc shares?
How can I buy Rocket Pharmaceuticals Inc shares from India?
Can Fractional shares of Rocket Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Rocket Pharmaceuticals Inc stocks?
What is today’s traded volume of Rocket Pharmaceuticals Inc?
What is today’s market capitalisation of Rocket Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Rocket Pharmaceuticals Inc?
What percentage is Rocket Pharmaceuticals Inc down from its 52-Week High?
What percentage is Rocket Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$10.71
$-0.37
(-3.34%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.